Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.

18:42 07/09/2023

Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.

JP Morgan maintains its "overweight" rating on Zijin Gold International (02259) as the first quarter performance meets expectations.

Open-source securities: The long-term logic of insurance remains unchanged, optimistic about the opportunities for sector layout.

New stock news | Zhongji Innolight (300308.SZ) reportedly plans to go public in Hong Kong as early as June, aiming to raise $5 billion.

JP Morgan maintains its "overweight" rating on Zijin Gold International (02259) as the first quarter performance meets expectations.

Open-source securities: The long-term logic of insurance remains unchanged, optimistic about the opportunities for sector layout.

New stock news | Zhongji Innolight (300308.SZ) reportedly plans to go public in Hong Kong as early as June, aiming to raise $5 billion.